
Eric Olson
Examiner (ID: 316, Phone: (571)272-9051 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1693, 1673, 1623 |
| Total Applications | 1758 |
| Issued Applications | 971 |
| Pending Applications | 175 |
| Abandoned Applications | 632 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5457815
[patent_doc_number] => 20090257967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'Compositions comprising sugar beet pectin and carotenoids'
[patent_app_type] => utility
[patent_app_number] => 12/456087
[patent_app_country] => US
[patent_app_date] => 2009-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2499
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20090257967.pdf
[firstpage_image] =>[orig_patent_app_number] => 12456087
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/456087 | Compositions comprising sugar beet pectin and carotenoids | Jun 9, 2009 | Abandoned |
Array
(
[id] => 9777982
[patent_doc_number] => 08853187
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-07
[patent_title] => 'Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/480086
[patent_app_country] => US
[patent_app_date] => 2009-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2957
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12480086
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/480086 | Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof | Jun 7, 2009 | Issued |
Array
(
[id] => 9299959
[patent_doc_number] => 08648187
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-11
[patent_title] => 'Method for separation of double-stranded and single-stranded nucleic acids from the same sample'
[patent_app_type] => utility
[patent_app_number] => 12/999325
[patent_app_country] => US
[patent_app_date] => 2009-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4504
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12999325
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/999325 | Method for separation of double-stranded and single-stranded nucleic acids from the same sample | Jun 1, 2009 | Issued |
Array
(
[id] => 5474315
[patent_doc_number] => 20090247481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'Compositions and Kits for Treating Influenza'
[patent_app_type] => utility
[patent_app_number] => 12/477105
[patent_app_country] => US
[patent_app_date] => 2009-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17194
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20090247481.pdf
[firstpage_image] =>[orig_patent_app_number] => 12477105
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/477105 | Compositions and kits for treating influenza | Jun 1, 2009 | Issued |
Array
(
[id] => 5490838
[patent_doc_number] => 20090291909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-26
[patent_title] => 'AMINOSUGAR, GLYCOSAMINOGLYCAN, AND S-ADENOSYLMETHIONINE COMPOSITION FOR THE TREATMENT AND REPAIR OF CONNECTIVE TISSUE'
[patent_app_type] => utility
[patent_app_number] => 12/473452
[patent_app_country] => US
[patent_app_date] => 2009-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7557
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20090291909.pdf
[firstpage_image] =>[orig_patent_app_number] => 12473452
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/473452 | AMINOSUGAR, GLYCOSAMINOGLYCAN, AND S-ADENOSYLMETHIONINE COMPOSITION FOR THE TREATMENT AND REPAIR OF CONNECTIVE TISSUE | May 27, 2009 | Abandoned |
Array
(
[id] => 5473652
[patent_doc_number] => 20090246818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'COMPOUNDS, METHODS, COMPLEXES, APPARATUSES AND USES RELATING TO STABILE FORMS OF NAD/NADH'
[patent_app_type] => utility
[patent_app_number] => 12/472105
[patent_app_country] => US
[patent_app_date] => 2009-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11789
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20090246818.pdf
[firstpage_image] =>[orig_patent_app_number] => 12472105
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/472105 | Compounds, methods, complexes, apparatuses and uses relating to stabile forms of NAD/NADH | May 25, 2009 | Issued |
Array
(
[id] => 6361804
[patent_doc_number] => 20100087641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-08
[patent_title] => 'Method and Materials for Quaternary Amine Catalyzed Bisulfite Conversion of Cytosine to Uracil'
[patent_app_type] => utility
[patent_app_number] => 12/468820
[patent_app_country] => US
[patent_app_date] => 2009-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6475
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20100087641.pdf
[firstpage_image] =>[orig_patent_app_number] => 12468820
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/468820 | Method and Materials for Quaternary Amine Catalyzed Bisulfite Conversion of Cytosine to Uracil | May 18, 2009 | Abandoned |
Array
(
[id] => 6589810
[patent_doc_number] => 20100130440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'ANTIVIRAL NUCLEOSIDES'
[patent_app_type] => utility
[patent_app_number] => 12/467939
[patent_app_country] => US
[patent_app_date] => 2009-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35573
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20100130440.pdf
[firstpage_image] =>[orig_patent_app_number] => 12467939
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/467939 | Antiviral nucleosides | May 17, 2009 | Issued |
Array
(
[id] => 6202872
[patent_doc_number] => 20110065658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'METHOD FOR TREATING HYPERURICEMIA EMPLOYING AN SGLT2 INHIBITOR AND COMPOSITION CONTAINING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/993750
[patent_app_country] => US
[patent_app_date] => 2009-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10079
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20110065658.pdf
[firstpage_image] =>[orig_patent_app_number] => 12993750
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/993750 | Method for treating hyperuricemia employing an SGLT2 inhibitor and composition containing same | May 14, 2009 | Issued |
Array
(
[id] => 8995011
[patent_doc_number] => 08518895
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-27
[patent_title] => 'Method for treating hyponatremia employing an SGLT2 inhibitor and composition containing same'
[patent_app_type] => utility
[patent_app_number] => 12/993766
[patent_app_country] => US
[patent_app_date] => 2009-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11105
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12993766
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/993766 | Method for treating hyponatremia employing an SGLT2 inhibitor and composition containing same | May 14, 2009 | Issued |
Array
(
[id] => 6120905
[patent_doc_number] => 20110077213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-31
[patent_title] => 'METHOD FOR TREATING AND PREVENTING KIDNEY STONES EMPLOYING AN SGLT2 INHIBITOR AND COMPOSITION CONTAINING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/993764
[patent_app_country] => US
[patent_app_date] => 2009-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10016
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20110077213.pdf
[firstpage_image] =>[orig_patent_app_number] => 12993764
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/993764 | Method for treating and preventing kidney stones employing an SGLT2 inhibitor and composition containing same | May 14, 2009 | Issued |
Array
(
[id] => 6376838
[patent_doc_number] => 20100076183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'PROTECTED MONOMER AND METHOD OF FINAL DEPROTECTION FOR RNA SYNTHESIS'
[patent_app_type] => utility
[patent_app_number] => 12/466326
[patent_app_country] => US
[patent_app_date] => 2009-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 36396
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20100076183.pdf
[firstpage_image] =>[orig_patent_app_number] => 12466326
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/466326 | PROTECTED MONOMER AND METHOD OF FINAL DEPROTECTION FOR RNA SYNTHESIS | May 13, 2009 | Abandoned |
Array
(
[id] => 6213916
[patent_doc_number] => 20110136754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'NOVEL TRIAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS'
[patent_app_type] => utility
[patent_app_number] => 12/990214
[patent_app_country] => US
[patent_app_date] => 2009-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13786
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20110136754.pdf
[firstpage_image] =>[orig_patent_app_number] => 12990214
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/990214 | Triazole derivatives, their preparation and their application in therapeutics | Apr 28, 2009 | Issued |
Array
(
[id] => 9020646
[patent_doc_number] => 08530632
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-10
[patent_title] => 'Chitosan-containing protective composition'
[patent_app_type] => utility
[patent_app_number] => 12/429150
[patent_app_country] => US
[patent_app_date] => 2009-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9992
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12429150
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/429150 | Chitosan-containing protective composition | Apr 22, 2009 | Issued |
Array
(
[id] => 6071510
[patent_doc_number] => 20110046361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'METHOD FOR SEPARATION OF DOUBLE-STRANDED AND SINGLE-STRANDED NUCLEIC ACIDS'
[patent_app_type] => utility
[patent_app_number] => 12/990242
[patent_app_country] => US
[patent_app_date] => 2009-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4120
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20110046361.pdf
[firstpage_image] =>[orig_patent_app_number] => 12990242
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/990242 | METHOD FOR SEPARATION OF DOUBLE-STRANDED AND SINGLE-STRANDED NUCLEIC ACIDS | Apr 21, 2009 | Abandoned |
Array
(
[id] => 6374495
[patent_doc_number] => 20100075914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'METHODS FOR TREATING HERPES VIRUS INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 12/425984
[patent_app_country] => US
[patent_app_date] => 2009-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 30987
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20100075914.pdf
[firstpage_image] =>[orig_patent_app_number] => 12425984
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/425984 | METHODS FOR TREATING HERPES VIRUS INFECTIONS | Apr 16, 2009 | Abandoned |
Array
(
[id] => 5480676
[patent_doc_number] => 20090203633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'PYRAZOLE DERIVATIVES, MEDICINAL COMPOSITION CONTAINING THE SAME, MEDICINAL USE THEREOF, AND INTERMEDIATE FOR PRODUCTION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/421236
[patent_app_country] => US
[patent_app_date] => 2009-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79838
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203633.pdf
[firstpage_image] =>[orig_patent_app_number] => 12421236
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/421236 | Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof | Apr 8, 2009 | Issued |
Array
(
[id] => 5315486
[patent_doc_number] => 20090280084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-12
[patent_title] => 'NUCLEOSIDE DERIVATIVES FOR TREATMENT OF CALICIVIRIDAE INFECTIONS, INCLUDING NOROVIRUS INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 12/421362
[patent_app_country] => US
[patent_app_date] => 2009-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20397
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20090280084.pdf
[firstpage_image] =>[orig_patent_app_number] => 12421362
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/421362 | Nucleoside derivatives for treatment of Caliciviridae infections, including Norovirus infections | Apr 8, 2009 | Issued |
Array
(
[id] => 5458684
[patent_doc_number] => 20090258836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'EFFECTIVE DELIVERY OF CROSS-SPECIES A3 ADENOSINE-RECEPTOR ANTAGONISTS TO REDUCE INTRAOCULAR PRESSURE'
[patent_app_type] => utility
[patent_app_number] => 12/419062
[patent_app_country] => US
[patent_app_date] => 2009-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12427
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258836.pdf
[firstpage_image] =>[orig_patent_app_number] => 12419062
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/419062 | EFFECTIVE DELIVERY OF CROSS-SPECIES A3 ADENOSINE-RECEPTOR ANTAGONISTS TO REDUCE INTRAOCULAR PRESSURE | Apr 5, 2009 | Abandoned |
Array
(
[id] => 9749962
[patent_doc_number] => 08841440
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-23
[patent_title] => 'Organo-soluble chitosan salts and chitosan-derived biomaterials prepared thereof'
[patent_app_type] => utility
[patent_app_number] => 12/935660
[patent_app_country] => US
[patent_app_date] => 2009-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11009
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12935660
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/935660 | Organo-soluble chitosan salts and chitosan-derived biomaterials prepared thereof | Mar 31, 2009 | Issued |